Authors

Crisis Point: Turning the Tide in The Opioid Crisis

In part 2 of this episode of Crisis Point, 4 experts on pain and opioid misuse discuss continuing efforts to turn the tide.

Addressing Treatment Challenges and Advancing Care in Psoriasis

An examination of the physical, emotional and social burden of psoriasis, and the continued need for research to advance care for patients.

Teach Your Children the Value of Money

Making the Grade: How Doctor-grading Websites Can Impact Your Practice, and What You Can Do to Lessen the Blow

Should your practice have a policy for responding to negative comments about the quality of care and service delivered by you and your staff left anonymously on an online physician-grading website?

ASH Interview Series

The December issue of Oncology & Biotech News featured highlights from the 51st American Society of Hematology (ASH) Annual Meeting and Exposition. We wrap up our ASH coverage this month with interviews on multiple myeloma with Brian G.M. Durie, MD, medical director and co-founder of the International Myeloma Foundation; chronic lymphocytic leukemia (CLL) with Robert J. Kreitman, MD, from the National Cancer Institute; and chronic myeloid leukemia (CML) with Francis J. Giles, MD, Cancer Therapy and Research Center at The University of Texas Health Science Center in San Antonio.

Right to Try: Limited Resolve, Endless Hope

Legislators and a libertarian think-tank have flaunted the merits of the Right-to-Try experimental drug policy. But physicians question its value and the message it sends to patients.

Shift a Passion for Cars into an Investment

Spironolactone and hyperkalemia in congestive heart failure

In 1999 Pitt and colleagues published the results of the RALES trial, an important study showing that the addition of a relatively small dose of the aldosterone antagonist spironolactone to a regimen that included angiotensin-converting enzyme (ACE) in­hibitors for patients with severe congestive heart failure (NYHA Class III-IV) had a striking benefit on mortality

White-coat hypertension and the development of sustained hypertension

For 50 years, hypertension has been recognized as the most significant risk factor for the development of symptomatic cardiovascular disease in Western society.

Mutual Funds Maintain Corporate Integrity

Long-term diuretic use and increased mortality and hospitalization in heart failure

Diuretic use has long been a mainstay in the management of symptomatic heart failure with pulmonary or systemic congestion, or both.

Beneficial Effects of Growth Hormone on Body Composition and CV Risk Factors in Obese Men

Study results show improvements in body composition, intrahepatic lipids, and cardiovascular risk markers in obese men treated with growth hormone for six months compared with placebo.

Julie Harper, MD: How Our Dermatology Practice is Using Telemedicine

A dermatologist and clinical associate professor of dermatology discusses implementing telehealth in dermatology practices.